Opthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare Conference
Opthea Limited - American Depositary Shares (OPT)
Company Research
Source: GlobeNewswire
MELBOURNE, Australia and PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that management will present and participate in one-on-one investor meetings at the following two investor conferences in September 2024: H.C. Wainwright 26th Annual Global Investment ConferencePresentation:Monday, September 9, 2024, 7:00 AM ETPresenter:Frederic Guerard, PharmD, CEOThe webcast will be accessible via the link: https://journey.ct.events/view/19df556a-f376-4c6d-af5b-d8220d561640 Cantor 2024 Global Healthcare ConferencePresentation:Tuesday, September 17, 2024, 8:35 AM ETPresenter:Frederic Guerard, PharmD, CEOThe webcast will be accessible via the link: https://wsw.com/webcast/cantor22/register.aspx?conf=cantor22&page=opt&url=https://ws
Show less
Read more
Impact Snapshot
Event Time:
OPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPT alerts
High impacting Opthea Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
OPT
News
- Opthea Appoints Kathy Connell to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Opthea Appoints Kathy Connell to Board of DirectorsGlobeNewswire
- Opthea’s Wet AMD Program Featured at Ophthalmology EventsGlobeNewswire
- Age-Related Macular Degeneration (AMD) Drugs Market Research 2024: Lucentis, Eylea, Eylea HD, Vabysmo, Syfovre, Ranibizumab, Aflibercept, Faricimab, Biologic, Biosimilar - Global Forecast to 2029 [Yahoo! Finance]Yahoo! Finance
- Opthea to Participate in November Investor ConferencesGlobeNewswire
OPT
Sec Filings
- 11/19/24 - Form 6-K
- 11/15/24 - Form 6-K
- 11/14/24 - Form SC
- OPT's page on the SEC website